Embed

Academic

Authors

Esther M. de Kruijf

Esther M. de Kruijf,Leiden University,Oncology,Anatomy

Edit

Esther M. de Kruijf

Leiden University

Publications: 8 | Citations: 12

Fields: Oncology, Anatomy

Collaborated with 36 co-authors from 2009 to 2011 | Cited by 80 authors

Cumulative Annual

Sort by:

Publications (8)

BibTeX | RIS | RefWorks Download

COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients (Citations: 4)

, , , , , , , , ,

Journal: Breast Cancer Research and Treatment - BREAST CANCER RES TREAT , vol. 125, no. 3, pp. 671-685, 2011

Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients (Citations: 2)

, , , , , , ,

Journal: Breast Cancer Research and Treatment - BREAST CANCER RES TREAT , vol. 125, no. 3, pp. 687-696, 2011

Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=48809905&selfId1=25126529&selfId2=0&maxNumber=12&query=

Journal: Breast Cancer Research - BREAST CANCER RES , vol. 13, no. 4, pp. 1-12, 2011

The Predictive Value of HLA Class I Tumor Cell Expression and Presence of Intratumoral Tregs for Chemotherapy in Patients with Early Breast Cancer (Citations: 6)

, , , , , , , , ,

Journal: Clinical Cancer Research - CLIN CANCER RES , vol. 16, no. 4, pp. 1272-1280, 2010

398 HLA-E and HLA-G tumour expression is of prognostic value for clinical outcome of early breast cancer patients, but exclusively in classical HLA class I tumor-negative patients

, , , , , , , ,

Journal: Ejc Supplements - EJC SUPPL , vol. 8, no. 3, pp. 173-173, 2010

Sort by:

Citations (12 times by 12 publications)

A gene expression signature identifies two prognostic subgroups of basal breast cancer (Citations: 4)

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=29114447&selfId1=25126529&selfId2=0&maxNumber=12&query=

Journal: Breast Cancer Research and Treatment - BREAST CANCER RES TREAT , vol. 126, no. 2, pp. 407-420, 2011

Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=48809905&selfId1=25126529&selfId2=0&maxNumber=12&query=

Journal: Breast Cancer Research - BREAST CANCER RES , vol. 13, no. 4, pp. 1-12, 2011

Immune parameters affecting the efficacy of chemotherapeutic regimens

, ,

Journal: Nature Reviews Clinical Oncology - NAT REV CLIN ONCOL , vol. 8, no. 3, pp. 151-160, 2011

Genomics, histopathology, and the tumor microenvironment: new relationship or old friends re-discovered?

Journal: Breast Cancer Research and Treatment - BREAST CANCER RES TREAT , vol. 125, no. 3, pp. 697-698, 2011

TIA-1 Cytotoxic Granule-Associated RNA Binding Protein Improves the Prognostic Performance of CD8 in Mismatch Repair-Proficient Colorectal Cancer (Citations: 1)

, , , , , , , , , ,

Journal: PLOS One , vol. 5, no. 12, 2010

Comments

Co-authors (36)

Journals (4)

Keywords (29)

Esther M. de Kruijf,Leiden University,Oncology,Anatomy

Publications (8)

BibTeX | RIS | RefWorks Download

COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients (Citations: 4)

Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients (Citations: 2)

Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10

The Predictive Value of HLA Class I Tumor Cell Expression and Presence of Intratumoral Tregs for Chemotherapy in Patients with Early Breast Cancer (Citations: 6)

398 HLA-E and HLA-G tumour expression is of prognostic value for clinical outcome of early breast cancer patients, but exclusively in classical HLA class I tumor-negative patients

Citations (12 times by 12 publications)

A gene expression signature identifies two prognostic subgroups of basal breast cancer (Citations: 4)

Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10

Immune parameters affecting the efficacy of chemotherapeutic regimens

Genomics, histopathology, and the tumor microenvironment: new relationship or old friends re-discovered?

TIA-1 Cytotoxic Granule-Associated RNA Binding Protein Improves the Prognostic Performance of CD8 in Mismatch Repair-Proficient Colorectal Cancer (Citations: 1)


	View FAQ about top research areas and Fields of study

Esther M. de Kruijf,Leiden University,Oncology,Anatomy

Publications (8) BibTeX | RIS | RefWorks Download

COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients (Citations: 4)

Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients (Citations: 2)

The Predictive Value of HLA Class I Tumor Cell Expression and Presence of Intratumoral Tregs for Chemotherapy in Patients with Early Breast Cancer (Citations: 6)

A gene expression signature identifies two prognostic subgroups of basal breast cancer (Citations: 4)

TIA-1 Cytotoxic Granule-Associated RNA Binding Protein Improves the Prognostic Performance of CD8 in Mismatch Repair-Proficient Colorectal Cancer (Citations: 1)

Publications (8)

BibTeX | RIS | RefWorks Download